دورية أكاديمية

Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان: Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma
المؤلفون: Facon, Thierry, Kumar, Shaji K, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, Perrot, Aurore, Weisel, Katja, Raje, Noopur, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Wang, Jianping, Rampelbergh, Rian Van, Uhlar, Clarissa M, Vermeulen, Jessica, Duran, Joana, Borgsten, Fredrik, Usmani, Saad Z
المساهمون: AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, CARsgen, Janssen, Molecular Templates, Novartis, Roche-Genentech, Takeda, TeneoBio
المصدر: Future Oncology ; volume 19, issue 13, page 887-895 ; ISSN 1479-6694 1744-8301
بيانات النشر: Informa UK Limited
سنة النشر: 2023
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.2217/fon-2023-0082
الإتاحة: https://doi.org/10.2217/fon-2023-0082Test
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.850968CA
قاعدة البيانات: BASE